Skip to main content
. 2018 Jul 19;7(2):233–248. doi: 10.1007/s40120-018-0105-0

Table 1.

Differentiating characteristics of drug-induced parkinsonism (DIP) versus tardive dyskinesia (TD)

Characteristic DIP TD
Onset Immediate (hours–days–weeks) after initiation of an antipsychotic or after dose is increased Delayed (months–years) after initiation of an antipsychotic
Motor symptoms observed Rhythmic tremor, rigidity, shuffling gait; akathisia may be present Arrhythmic movements (generally choreo-athetoid) of the face, trunk and extremities
Immediate (hours–days–weeks) effects of increasing antipsychotic dose Worsens Improves
Immediate (hours–days–weeks) effects of decreasing antipsychotic dose Improves Worsens
Effects of anticholinergic medications (e.g., benztropine) Improves Can worsen
Pharmacotherapeutic treatment options Anticholinergics (for example, benztropine), amantadine VMAT2 inhibitors (tetrabenazine, valbenazine, deutetrabenazine), Ginkgo biloba, clonazepam, amantadine

VMAT2 vesicular monoamine transporter 2